Published in BMC Med on April 07, 2009
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature (2011) 4.04
Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol Dis (2009) 1.29
Role of TGF-β signaling in inherited and acquired myopathies. Skelet Muscle (2011) 1.28
Proteomic assessment of a cell model of spinal muscular atrophy. BMC Neurosci (2011) 1.05
Histone deacetylase inhibition suppresses myogenin-dependent atrogene activation in spinal muscular atrophy mice. Hum Mol Genet (2012) 0.98
Mechanism of neuromuscular dysfunction in Krabbe disease. J Neurosci (2015) 0.84
eIF4EBP3L acts as a gatekeeper of TORC1 in activity-dependent muscle growth by specifically regulating Mef2ca translational initiation. PLoS Biol (2013) 0.83
SMA-MAP: a plasma protein panel for spinal muscular atrophy. PLoS One (2013) 0.82
Systems analysis of transcriptional data provides insights into muscle's biological response to botulinum toxin. Muscle Nerve (2014) 0.80
Impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients. Muscle Nerve (2012) 0.80
Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, that Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy. ACS Chem Neurosci (2012) 0.80
Conditional expression of TGF-β1 in skeletal muscles causes endomysial fibrosis and myofibers atrophy. PLoS One (2013) 0.80
Differential induction of muscle atrophy pathways in two mouse models of spinal muscular atrophy. Sci Rep (2016) 0.76
VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models. Orphanet J Rare Dis (2014) 0.76
An Integrative Transcriptomic Analysis for Identifying Novel Target Genes Corresponding to Severity Spectrum in Spinal Muscular Atrophy. PLoS One (2016) 0.75
A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80
Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A (2002) 30.32
Identification and characterization of a spinal muscular atrophy-determining gene. Cell (1995) 17.41
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell (2004) 11.33
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol (2001) 10.85
Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J (1998) 9.36
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J (2004) 7.02
Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet (1997) 6.08
The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell (1995) 5.50
Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J (1997) 5.49
Control of cell number by Drosophila FOXO: downstream and feedback regulation of the insulin receptor pathway. Genes Dev (2003) 5.10
The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet (1997) 4.86
A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell (1998) 4.47
SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet (1998) 3.51
Interleukin-32: a cytokine and inducer of TNFalpha. Immunity (2005) 3.39
Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J (2006) 3.27
PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet (1995) 2.40
Patterns of gene expression in atrophying skeletal muscles: response to food deprivation. FASEB J (2002) 2.29
Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2. Mol Cell Biol (2001) 2.19
Intracellular signaling during skeletal muscle atrophy. Muscle Nerve (2006) 2.13
Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol (2004) 2.13
Molecular mechanisms modulating muscle mass. Trends Mol Med (2003) 1.77
Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy. J Cell Biol (2001) 1.64
A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle. J Cell Biol (2007) 1.60
Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. Am J Hum Genet (1998) 1.56
Spinal muscular atrophy: the RNP connection. Trends Mol Med (2006) 1.38
Is spinal muscular atrophy the result of defects in motor neuron processes? Bioessays (2005) 1.33
Complementary techniques: validation of gene expression data by quantitative real time PCR. Adv Exp Med Biol (2007) 1.32
Denervation in murine fast-twitch muscle: short-term physiological changes and temporal expression profiling. Physiol Genomics (2005) 1.27
Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy. Sci STKE (2004) 1.10
SMA carrier testing--validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion. Eur J Hum Genet (2000) 1.03
Apoptotic signaling in skeletal muscle fibers during atrophy. Curr Opin Clin Nutr Metab Care (2002) 0.90
Expression profiling characterization of laminin alpha-2 positive MDC. Biochem Biophys Res Commun (2006) 0.78
Evolution of muscle specific proteins in Werdnig-Hoffman's disease. J Neurol Sci (1992) 0.78
Degeneration of cocultures of spinal muscular atrophy muscle cells and rat spinal cord explants is not due to secreted factors and cannot be prevented by neurotrophins. Muscle Nerve (1997) 0.77
Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation (2006) 2.81
Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain (2006) 2.22
Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat Protoc (2012) 2.12
Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. Am J Hum Genet (2012) 1.88
Analysis of the human VPS13 gene family. Genomics (2004) 1.65
Identification of 45 novel mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Hum Mutat (2006) 1.61
MIDAW: a web tool for statistical analysis of microarray data. Nucleic Acids Res (2005) 1.60
Rippling muscle disease and facioscapulohumeral dystrophy-like phenotype in a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion: Further evidence for "double trouble" overlapping syndromes. Neuromuscul Disord (2012) 1.59
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation. Neurology (2013) 1.55
A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia. Haematologica (2005) 1.50
Ultrastructural changes in LGMD1F. Neuropathology (2012) 1.43
Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Genet (2011) 1.33
Gene expression profiling in dysferlinopathies using a dedicated muscle microarray. Hum Mol Genet (2002) 1.32
Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J (2006) 1.31
Investigating the mechanism of chromosomal deletion: characterization of 39 deletion breakpoints in introns 47 and 48 of the human dystrophin gene. Genomics (2002) 1.30
Pattern recognition in gene expression profiling using DNA array: a comparative study of different statistical methods applied to cancer classification. Hum Mol Genet (2003) 1.29
Denervation in murine fast-twitch muscle: short-term physiological changes and temporal expression profiling. Physiol Genomics (2005) 1.27
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1. FASEB J (2012) 1.27
A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function. Hum Mol Genet (2008) 1.20
Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J Neurol Sci (2007) 1.20
Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload. Circ Res (2005) 1.19
MytiBase: a knowledgebase of mussel (M. galloprovincialis) transcribed sequences. BMC Genomics (2009) 1.18
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. Neurology (2012) 1.17
Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations. Eur J Hum Genet (2011) 1.16
Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries. BMC Genomics (2009) 1.16
A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score. Muscle Nerve (2010) 1.15
JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy. J Cell Biol (2010) 1.14
Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients. J Transl Med (2010) 1.13
Differential gene expression profiling in genetic and multifactorial cardiovascular diseases. J Mol Cell Cardiol (2006) 1.13
Missense mutations in desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro. BMC Med Genet (2007) 1.11
The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender? J Neurol (2013) 1.09
Myelo-optico-neuropathy in copper deficiency occurring after partial gastrectomy. Do small bowel bacterial overgrowth syndrome and occult zinc ingestion tip the balance? J Neurol (2007) 1.07
MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy. Neuromuscul Disord (2007) 1.07
Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease. Am J Pathol (2006) 1.07
Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency. Neurology (2008) 1.07
Motor function-muscle strength relationship in spinal muscular atrophy. Muscle Nerve (2004) 1.07
Next-generation sequencing identifies transportin 3 as the causative gene for LGMD1F. PLoS One (2013) 1.07
Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy. Biochem Biophys Res Commun (2003) 1.06
Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression. Am J Pathol (2003) 1.05
The frequency of limb girdle muscular dystrophy 2A in northeastern Italy. Neuromuscul Disord (2005) 1.05
Insights into the innate immunity of the Mediterranean mussel Mytilus galloprovincialis. BMC Genomics (2011) 1.05
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. Brain (2013) 1.05
Optimization of respiratory chain enzymatic assays in muscle for the diagnosis of mitochondrial disorders. Mitochondrion (2011) 1.03
Analysis of miRNA and mRNA expression profiles highlights alterations in ionizing radiation response of human lymphocytes under modeled microgravity. PLoS One (2012) 1.02
Meta-analysis of expression signatures of muscle atrophy: gene interaction networks in early and late stages. BMC Genomics (2008) 1.02
Microgenomic analysis in skeletal muscle: expression signatures of individual fast and slow myofibers. PLoS One (2011) 1.02
Gene expression profiling identifies potential relevant genes in alveolar rhabdomyosarcoma pathogenesis and discriminates PAX3-FKHR positive and negative tumors. Int J Cancer (2006) 1.02
Molecular and muscle pathology in a series of caveolinopathy patients. Hum Mutat (2005) 1.02
Phenotype modulators in myophosphorylase deficiency. Ann Neurol (2003) 1.02
Development of mussel mRNA profiling: Can gene expression trends reveal coastal water pollution? Mutat Res (2006) 1.02
Decorin and biglycan expression is differentially altered in several muscular dystrophies. Brain (2005) 1.01
Muscle Research and Gene Ontology: New standards for improved data integration. BMC Med Genomics (2009) 1.01
Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul Disord (2009) 1.01
Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul Disord (2004) 0.99
Integrin alpha 7 beta 1 in muscular dystrophy/myopathy of unknown etiology. Am J Pathol (2002) 0.98
Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study. J Child Neurol (2003) 0.98
Redefining phenotypes associated with mitochondrial DNA single deletion. J Neurol (2015) 0.98
Clinical and genetic characterization of Chanarin-Dorfman syndrome. Biochem Biophys Res Commun (2008) 0.97
Human MYO18B, a novel unconventional myosin heavy chain expressed in striated muscles moves into the myonuclei upon differentiation. J Mol Biol (2003) 0.97
Towards a catalogue of genes transcribed in multiple tissues of Mytilus galloprovincialis. Gene (2003) 0.97
Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I. Arch Neurol (2005) 0.96
Telethon Network of Genetic Biobanks: a key service for diagnosis and research on rare diseases. Orphanet J Rare Dis (2013) 0.96
Dominant muscular dystrophy with a novel SYNE1 gene mutation. Muscle Nerve (2014) 0.96
Defining the gene expression signature of rhabdomyosarcoma by meta-analysis. BMC Genomics (2006) 0.95
Improved detection of differentially expressed genes in microarray experiments through multiple scanning and image integration. Nucleic Acids Res (2003) 0.95
Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2. Muscle Nerve (2008) 0.93
TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle. J Pathol (2012) 0.93
Risk prediction for clinical phenotype in myotonic dystrophy type 1: data from 2,650 patients. Genet Test (2007) 0.92
CHIT1 and AMCase expression in human gastric mucosa: correlation with inflammation and Helicobacter pylori infection. Eur J Gastroenterol Hepatol (2009) 0.92
Progress in Enzyme Replacement Therapy in Glycogen Storage Disease Type II. Ther Adv Neurol Disord (2009) 0.91
Systematic sequencing of mRNA from the Antarctic krill (Euphausia superba) and first tissue specific transcriptional signature. BMC Genomics (2008) 0.91
The mammalian CHORD-containing protein melusin is a stress response protein interacting with Hsp90 and Sgt1. FEBS Lett (2008) 0.91
How to tackle the diagnosis of limb-girdle muscular dystrophy 2A. Eur J Hum Genet (2008) 0.91
TRAIT (TRAnscript Integrated Table): a knowledgebase of human skeletal muscle transcripts. Bioinformatics (2003) 0.91
The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia. J Gastrointest Surg (2004) 0.90
Impaired autophagy contributes to muscle atrophy in glycogen storage disease type II patients. Autophagy (2012) 0.90
Recessive MYL2 mutations cause infantile type I muscle fibre disease and cardiomyopathy. Brain (2013) 0.90
The p.A897KfsX4 frameshift variation in desmocollin-2 is not a causative mutation in arrhythmogenic right ventricular cardiomyopathy. Eur J Hum Genet (2010) 0.89
The effects of Ankrd2 alteration indicate its involvement in cell cycle regulation during muscle differentiation. Biochim Biophys Acta (2008) 0.89
Amyotrophic lateral sclerosis with ragged-red fibers. Arch Neurol (2008) 0.89